Clinical Significance of the Bacille Calmette-Guérin Site Reaction in Kawasaki Disease Patients Aged Less than 18 Months
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to investigate the clinical significance of Bacille Calmette-Guérin (BCG) site reaction in terms of diagnosis and outcome prediction in young children with Kawasaki disease (KD). Methods: The incidence of BCG site reaction in the respective age ranges was investigated in 1,058 patients who were admitted at Asan Medical Center between January 2006 and February 2017. The 416 patients under 18 months of age were enrolled as subjects for the analysis of the association between BCG site reaction and other laboratory and clinical findings. The analysis was performed separately in complete and incomplete KD groups. Results: The incidence rate of BCG site reaction was peaked at 6–12 months (83%) and decreased with increasing age after 12 months in 1,058 patients ( P <0.001). The incidence rate was above 70% in KD aged less than 18 months and more frequent than those of cervical lymphadenopathy. The logistic regression analyses showed that the principal clinical findings including conjunctivitis ( P =0.781), red lips/oral mucosa ( P =0.963), rash ( P =0.510), cervical lymphadenopathy ( P =0.363), changes in extremities ( P =0.283) and the coronary artery aneurysm ( P =0.776) were not associated with the BCG site reaction. Conclusions: The BCG site reaction could be a useful diagnostic tool independent to principal clinical findings in KD developing in children aged <18 months, who underwent BCG vaccination. Outcome of KD patients was not different between groups with or without the BCG site reaction in both complete KD and incomplete KD.
Abstract
Purpose: The purpose of this study was to investigate the clinical significance of Bacille Calmette-Guérin (BCG) site reaction in terms of diagnosis and outcome prediction in young children with Kawasaki disease (KD). Methods: The incidence of BCG site reaction in the respective age ranges was investigated in 1,058 patients who were admitted at Asan Medical Center between January 2006 and February 2017. The 416 patients under 18 months of age were enrolled as subjects for the analysis of the association between BCG site reaction and other laboratory and clinical findings. The analysis was performed separately in complete and incomplete KD groups. Results: The incidence rate of BCG site reaction was peaked at 6–12 months (83%) and decreased with increasing age after 12 months in 1,058 patients ( P <0.001). The incidence rate was above 70% in KD aged less than 18 months and more frequent than those of cervical lymphadenopathy. The logistic regression analyses showed that the principal clinical findings including conjunctivitis ( P =0.781), red lips/oral mucosa ( P =0.963), rash ( P =0.510), cervical lymphadenopathy ( P =0.363), changes in extremities ( P =0.283) and the coronary artery aneurysm ( P =0.776) were not associated with the BCG site reaction. Conclusions: The BCG site reaction could be a useful diagnostic tool independent to principal clinical findings in KD developing in children aged <18 months, who underwent BCG vaccination. Outcome of KD patients was not different between groups with or without the BCG site reaction in both complete KD and incomplete KD.
참고문헌 (19)
- McCrindle BW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association", Circulation, 135, pp.e927~e999 (2017)
- Uehara R, "Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site", Pediatr Infect Dis J, 29, pp.430~433 (2010)
- Rezai MS, "Erythema at BCG inoculation site in Kawasaki disease patients", Mater Sociomed, 26, pp.256~260 (2014)
- 서지혜, "Diagnosis of Incomplete Kawasaki Disease in Infants Based on an Inflammation at the Bacille Calmette-Guérin Inoculation Site", Korean Circulation Journal, 42(12), pp.823~829 (2012), 대한심장학회
- 이수정, "3개월 이하 영아에서 가와사끼병의 임상 특징", Clinical and Experimental Pediatrics, 46(6), pp.591~596 (2003), 대한소아청소년과학회
- Hong CE, "Pediatrics", pp.1276~1278 (2016), Mirae N Co., Ltd
- Lai CC, "Reaction at the Bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease", Pediatr Neonatol, 54, pp.43~48 (2013)
- Garrido-García LM, "Reaction of the BCG scar in the acute phase of Kawasaki disease in Mexican children", Pediatr Infect Dis J, 36, pp.e237~e241 (2017)
- McCrindle BW, "Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements", Circulation, 116, pp.174~179 (2007)
- World Health Organization, "BCG vaccine. WHO position paper", Wkly Epidemiol Rec, 79, pp.27~38 (2004)
- 최영준, "Comparative Estimation of Coverage between National Immunization Program Vaccines and Non-NIP Vaccines in Korea", Journal of Korean Medical Science, 28(9), pp.1283~1288 (2013), 대한의학회
- Lee HJ, "Classification of vaccination and immunization schedule recommended by the Korean Pediatric Society, 2008", J Korean Med Assoc, 51, pp.104~109 (2008)
- Yang HI, "National immunization survey in South Korea, 2013", Public Health Wkly Rep, 7, pp.449~454 (2014)
- Kim GB, "Epidemiology and clinical features of Kawasaki disease in South Korea, 2012–201", Pediatr Infect Dis J, 36, pp.482~485 (2017)
- Lin MT, "Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG scar reactivation", Pediatr Infect Dis J, 30, pp.148~152 (2011)
- Manlhiot C, "Kawasaki disease at the extremes of the age spectrum", Pediatrics, 124, pp.e410~e415 (2009)
- Chang FY, "Characteristics of Kawasaki disease in infants younger than six months of age", Pediatr Infect Dis J, 25, pp.241~244 (2006)
- Song D, "Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age", Eur J Pediatr, 168, pp.1315~1321 (2009)
- Takayama J, "Study of the changes of the site of the BCG inoculation in MCLS", JPN J Pediatr, 86, pp.567~572 (1982)